| 缺血性脑卒中二级预防中的抗血小板治疗及其研究进展 |
| |
| 引用本文： | 王天瑶,代大伟,范宇威,张黎明.缺血性脑卒中二级预防中的抗血小板治疗及其研究进展[J].中国临床神经科学,2014(5):573-576. |
| |
| 作者姓名： | 王天瑶 代大伟 范宇威 张黎明 |
| |
| 作者单位： | 哈尔滨医科大学附属第一医院神经内科,150001 |
| |
| 基金项目： | 国家自然科学基金项目（编号：81271288） |
| |
| 摘 要： | 抗血小板治疗是缺血性脑卒中二级预防中影响脑卒中再发率的重要因素。阿司匹林和氯吡格雷是临床常用的抗血小板药物。缺血性脑卒中二级预防中抗血小板药物的联合应用以及新药的研究已成为时下热点。由于缺血性脑卒中发病后早期再发率较高,因此早期以及长期二级预防中的抗血小板治疗方式不尽相同。
|
| 关 键 词： | 抗血小板治疗 二级预防 缺血性脑卒中 阿司匹林 氯吡格雷 |
Antiplatelet Theraphy in the Secondary Prevention of Ischemic Stroke and Its Development |
| |
| WANG Tian-yao,DAI Da-wei,FAN Yu-wei,ZHANG LI-ming.Antiplatelet Theraphy in the Secondary Prevention of Ischemic Stroke and Its Development[J].Chinese Journal of Clinical Neurosciences,2014(5):573-576. |
| |
| Authors: | WANG Tian-yao DAI Da-wei FAN Yu-wei ZHANG LI-ming |
| |
| Institution: | (Department of Neurology, the First Hospital Affiliated to Harbin Medical University, Harbin 150001, China) |
| |
| Abstract: | Antiplatelet theraphy is a major player influencing the rate of recurrent stroke for secondary stroke prevention. Aspirin and clopidogrel are the commonly prescribed antiplatelet agents. They have become research hotspots for investigating combination of antiplatelet agents as well as development of novel agents. Since the rate of recurrent stroke are higher during the early stage after ischaemic stroke, early and long-term antiplatelet therapy of secondary stroke prevention are not always the same. |
| |
| Keywords: | antiplatelet theraphy secondary prevention ischemic stroke aspirin clopidogrel |
| 本文献已被 CNKI 维普 等数据库收录！ |
